Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion (Q73185913)
Jump to navigation
Jump to search
scientific article published on 01 November 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion |
scientific article published on 01 November 1999 |
Statements
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion (English)
G J Martin
S D Boden
1 November 1999
2188-93; discussion 2193-4